Furthermore, considering tumor heterogeneity, the release of a wide variety of distinct TAs would intuitively increase the chance of successful priming of anti-TA T cells and the constitution of a wide clonal T-cell repertoire, leading to an efficient CD8+-mediated cytotoxic effect towards shared TA in distinct lesions. Here, CD8A is linked to neoplasm.